In conclusion, while CXCR3 provides an advantage to CD4+ T cells for recruitment to the lungs in response to this pulmonary TB vaccine, it is not essential for the development and retention of lung-resident memory CD4+ T cells. This evidence concerns the gene CXCR3 and tuberculosis.